#IOVA Iovance Biotherapeutics Appoints Noah Berkowitz, M.D., Ph.D., as Chief Medical Officer

#IOVA Iovance Biotherapeutics Appoints Noah Berkowitz, M.D., Ph.D., as Chief Medical Officer
#IOVA Iovance Biotherapeutics Raises Full Year 2026 Revenue Guidance to $410 to $420 Million
#IOVA Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)